MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.35 0.05 (2.13%)	0.02 (0.84%)	0.02 (0.84%)	0.09 (3.9%)	0.05 (2.13%)	-0.01 (-0.75%)	0.9 (67.67%)	1.07 (80.45%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -26.6667
Diluted P/E:: -26.6667
RSI(14) 1m:: 73.23
VWAP:: 2.38
RVol:: 13.9323

Events

Period	Kind	Movement	Occurred At
10m	Price decrease 10m	2.77 -0.1 (-3.48%)	Oct 16 05:54
1m	Price decrease 1m	2.8 -0.04 (-1.41%)	Oct 16 05:53
1m	Price decrease 1m	2.82 -0.05 (-1.74%)	Oct 16 05:50
1m	Price increase 1m	2.87 +0.06 (+2.14%)	Oct 16 05:49
1m	Price decrease 1m	2.8 -0.11 (-3.78%)	Oct 16 05:47